The FTC action would target often high costs by trying to curb rebates it says drug makers pay to steer patients to their brand name products.
Related Posts
Beating cancer used to be bipartisan. What happened?
Lawmakers aren’t willing to meet the president’s budget requests, casting doubt on reaching the program’s ambitious goal.
FDA revokes emergency use of Covid-19 vaccines
The decision could make it difficult for young healthy children to get a Covid-19 shot.
Biden’s got pharma’s back in global pandemic treaty negotiations
For those countries and their advocates, it’s a striking stance — given what happened after Covid arrived: They shared data about new variants only to […]